Page 16 - AN-3-2

Advanced Neurology Limbic-predominant TDP-43 encephalopathy

doi: 10.1038/s41582-023-00846-7 37. Tomé SO, Tsaka G, Ronisz A, et al. TDP-43 pathology is
associated with increased tau burdens and seeding. Mol
27. Nelson PT, Lee EB, Cykowski MD, et al. LATE-NC staging
in routine neuropathologic diagnosis: An update. Acta Neurodegener. 2023;18(1):71.
Neuropathol. 2023;145(2):159-173. doi: 10.1186/s13024-023-00653-0
doi: 10.1007/s00401-022-02524-2 38. Latimer CS, Liachko NF. Tau and TDP-43 synergy: A novel
therapeutic target for sporadic late-onset Alzheimer’s
28. Maioli H, Mittenzwei R, Shofer JB, et al. Performance of
a condensed protocol to assess limbic-predominant age- disease. GeroScience. 2021;43(4):1627-1634.
related TDP-43 encephalopathy neuropathologic change. doi: 10.1007/s11357-021-00407-0
J Neuropathol Exp Neurol. 2023;82(7):611-619.
39. Leiby A-MC, Scambray KA, Nguyen HL, et al. Characterizing
doi: 10.1093/jnen/nlad035 limbic-predominant age-related TDP-43 encephalopathy
29. Besser LM, Teylan MA, Nelson PT. Limbic predominant without Alzheimer’s disease and lewy body dementia in the
age-related TDP-43 encephalopathy (LATE): Clinical and oldest old: A case series. J Alzheimers Dis. 2023;96(1):113-124.
neuropathological associations. J Neuropathol Exp Neurol. doi: 10.3233/JAD-230238
2020;79(3):305-313.
40. Ducharme S, Pijnenburg Y, Rohrer JD, Huey E,
doi: 10.1093/jnen/nlz126 Finger E, Tatton N. Identifying and diagnosing TDP-43
30. Robinson JL, Porta S, Garrett FG, et al. Limbic-predominant age- neurodegenerative diseases in psychiatry. Am J Geriatr
related TDP-43 encephalopathy differs from frontotemporal Psychiatry. 2024;32(1):98-113.
lobar degeneration. Brain. 2020;143(9):2844-2857. doi: 10.1016/j.jagp.2023.08.017
doi: 10.1093/brain/awaa219 41. Liu KY, Reeves S, McAleese KE, et al. Neuropsychiatric
31. Katsumata Y, Abner EL, Karanth S, et al. Distinct symptoms in limbic-predominant age-related TDP-43
clinicopathologic clusters of persons with TDP-43 encephalopathy and Alzheimer’s disease. Brain.
proteinopathy. Acta Neuropathol. 2020;140(5):659-674. 2020;143(12):3842-3849.
doi: 10.1007/s00401-020-02211-0 doi: 10.1093/brain/awaa315
32. Murakami A, Koga S, Sekiya H, et al. Old age amyotrophic 42. Koper MJ, Tomé SO, Gawor K, et al. LATE-NC aggravates
lateral sclerosis and limbic TDP-43 pathology. Brain Pathol. GVD-mediated necroptosis in Alzheimer’s disease. Acta
2022;32(6):e13100. Neuropathol Commun. 2022;10(1):128.
doi: 10.1111/bpa.13100 doi: 10.1186/s40478-022-01432-6
33. Hiya S, Maldonado-Díaz C, Walker JM, Richardson TE. 43. Walker JM, Richardson TE. Cognitive resistance to and
Cognitive symptoms progress with limbic-predominant age- resilience against multiple comorbid neurodegenerative
related TDP-43 encephalopathy stage and co-occurrence pathologies and the impact of APOE status. J Neuropathol
with Alzheimer disease. J Neuropathol Exp Neurol. Exp Neurol. 2023;82(2):110-119.
2023;83(1):2-10. doi: 10.1093/jnen/nlac115
doi: 10.1093/jnen/nlad098 44. Uemura MT, Robinson JL, Cousins KAQ, et al. Distinct
34. Gauthreaux KM, Teylan MA, Katsumata Y, et al. Limbic- characteristics of limbic-predominant age-related TDP-43
predominant age-related TDP-43 encephalopathy: encephalopathy in Lewy body disease. Acta Neuropathol.
Medical and pathologic factors associated with comorbid 2022;143(1):15-31.
hippocampal sclerosis. Neurology. 2022;98(14):e1422-e1433. doi: 10.1007/s00401-021-02383-3
doi: 10.1212/WNL.0000000000200001 45. Niedowicz DM, Katsumata Y, Nelson PT. In severe ADNC,
35. Gauthreaux K, Mock C, Teylan MA, et al. Symptomatic hippocampi with comorbid LATE-NC and hippocampal
profile and cognitive performance in autopsy-confirmed sclerosis have substantially more astrocytosis than those with
limbic-predominant age-related TDP-43 encephalopathy LATE-NC or hippocampal sclerosis alone. J Neuropathol
with comorbid Alzheimer disease. J Neuropathol Exp Neurol. Exp Neurol. 2023;82(12):987-994.
2022;81(12):975-987.
doi: 10.1093/jnen/nlad085
doi: 10.1093/jnen/nlac093
46. Teylan MA, Mock C, Gauthreaux K, et al. Differences in
36. Young AL, Vogel JW, Robinson JL, et al. Data-driven symptomatic presentation and cognitive performance
neuropathological staging and subtyping of TDP-43 among participants With LATE-NC compared to FTLD-
proteinopathies. Brain. 2023;146(7):2975-2988. TDP. J Neuropathol Exp Neurol. 2021;80(11):1024-1032.
doi: 10.1093/brain/awad145 doi: 10.1093/jnen/nlab098

Volume 3 Issue 2 (2024) 10 doi: 10.36922/an.2603